Night 7k to 12k Chennai City Center Call Girls 👉👉 7427069034⭐⭐ 100% Genuine E...
MassTLC healthcare seminar, Patient Engagement and the Role of Technology to Improve Outcomes and Lower Costs
1. Realizing the Promise of
Patient-Centered Care: What
Will It Take?
Dana Gelb Safran, ScD
Senior Vice President
Performance Measurement & Improvement
Massachusetts Healthcare Technology Leadership Council
Waltham, MA
8 June 2012
2. US Health Care Spending As a Percent of GDP
Highest Among Economically Developed Nations
Total Health Expenditures as a % of GDP, U.S. and Selected Countries (2003)
eOECD estimate. Source: Organisation for Economic Co-operation and Development. OECD Health Data 2006, from the OECD Internet subscription database
updated October 10, 2006. Copyright OECD 2006, http://www.oecd.org/health/healthdata.
Blue Cross Blue Shield of Massachusetts 2
3. US Annual Growth in % GDP Devoted to Health Care
Highest Among Economically Developed Nations
Growth in Health Care Spending as a % of GDP, U.S. and Selected Countries, 1980-2003
Blue Cross Blue Shield of Massachusetts 3
4. Despite Highest Per Capita Spending in the World,
US Health Lags Substantially
Per Capita Health Expenditures vs. Life Expectancy
Blue Cross Blue Shield of Massachusetts 4
5. Seeds of the Quality Imperative
IOM: Scoping the extent of
medical errors and system-
related harm
2000 2001 2003
RAND: Percent of
US population
IOM: Six receiving
Pillars of appropriate
High Quality preventive and
Health Care chronic care
Blue Cross Blue Shield of Massachusetts 5
6. Twin Goals of Improving Quality & Outcomes While
Significantly Slowing Spending Growth
In 2007, leaders at BCBSMA challenged the company to develop a
new contract model that would improve quality and outcomes while
significantly slowing the rate of growth in health care spending.
18.0%
MA health reform law (2006) 16.0% 15.9%
13.1% 13.3%
caused a bright light to shine 14.0%
12.0% 13.8% 12.8%
12.1%
on the issue of unrelenting 10.0%
8.0%
double-digit increases in 6.0%
8.2%
health care spending growth 4.0%
2.0%
(“Health Care Reform II). 0.0%
2000 2001 2002 2003 2004 2005 2006 2007 2008 2009
BCBSMA Workers’ Earnings
Medical Trend Overall Inflation
Sources: BCBSMA, Bureau of Labor Statistics
Blue Cross Blue Shield of Massachusetts 6
7. Components of the AQC Model
AQC Providers are Accountable for Quality and Cost
Performance Incentives Financial Structure
Promote
Promotes Affordability and
Quality, Safety and
Efficiency
Patient-Centered Care
Providers receive upside Providers share risk on a health
payments for performance on a status adjusted Total Medical
broad set of quality and patient Expense Budget
experience measures
Blue Cross Blue Shield of Massachusetts 7
8. AQC Measure Set for Performance Incentives
AMBULATORY HOSPITAL
PROCESS • Preventive screenings • Evidence-based care elements for:
• Acute care management • Heart attack (AMI)
• Heart failure (CHF)
• Chronic care management • Pneumonia
• Depression • Surgical infection prevention
• Diabetes
• Cardiovascular disease
OUTCOME • Control of chronic conditions • Post-operative complications
• Diabetes • Hospital-acquired infections
• Cardiovascular disease • Obstetrical injury
• Hypertension • Mortality (condition –specific)
• ***Triple weighted***
PATIENT • Access, Integration • Discharge quality, Staff
EXPERIENCE • Communication, Whole-person responsiveness
care • Communication (MDs, RNs)
DEVELOPMENTAL Up to 3 measures on priority topics for which measures lacking
Blue Cross Blue Shield of Massachusetts 8
9. AQC Improving Preventive and Chronic Care
The 2009 AQC cohort continues to demonstrate success improving quality –
achieving benchmarks significantly higher than non-AQC peers.
The 2010 AQC cohort made significant quality improvements in year-1 of
their contract (2009 vs. 2010).
Preventive Screenings Chronic Care Management
5 2009 AQC 2010 AQC 2009 AQC 2010 AQC
Non-AQC Non-AQC
Cohort Cohort Cohort Cohort
3.9
4 3.6
Optimal Care
3.3 3.3
3 2.7 2.5 2.6 2.7
2.5
2.3 2.2
2 2.1 1.9
2 1.8 1.7 1.8 1.7 1.7
1.2 1.1 1.1
0.9
1
0.5
0
2007 2008 2009 2010 2007 2008 2009 2010 2007 2008 2009 2010 2007 2008 2009 2010 2007 2008 2009 2010 2007 2008 2009 2010
Blue Cross Blue Shield of Massachusetts 9
10. Barriers to Adherence
Cognitive
Financial Logistical
Motivational
Blue Cross Blue Shield of Massachusetts 10
11. Essential Attributes of Primary Care Measured by the
Ambulatory Care Experiences Survey (ACES)
Access
financial
14 2/7 %
organizational
Trust
14 2/7 %
Continuity
14longitudinal
2/7 %
visit based
Interpersonal Primary
14 2/7 %
Treatment
Care Comprehensiveness
knowledge of
patient %
14 2/7
preventive
Clinical Interaction
14 2/7 % counseling
communication
physical exams 14 2/7 %
Integration
Source: Safran DG et al. JGIM 2006; 21(1):13-21.
Blue Cross Blue Shield of Massachusetts 11
12. Clinical Relationship Quality Is A Leading
Predictor of Outcomes
Business Outcomes
Loyalty to the practice (voluntary disenrollment)
Malpractice Risk
Recommending the practice
Health Outcomes
Adherence to Clinical Advice
Symptom Resolution
Improved Clinical Indicators
Blue Cross Blue Shield of Massachusetts 12
13. Patient Trust as a Predictor of Adherence:
Successful Behavior Change
1996 Trust (percentile)
95th 32.9%
75th 31.7%
50th 29.9%
25th 28.0%
5th 24.3%
0 20 25 30 35
% Successful Change
Source: Safran et al. JGIM 2000; 15 (supp):116.
Blue Cross Blue Shield of Massachusetts 13
14. Patient Preference for Active Involvement in
Medical
Decision-Making: Effect of Patient Intervention
30
25 24.3*
Experimental Group
Control Group
19.4 19.2
20 18.7
15
10
5
0
Pre-Intervention Post-Intervention
Source: Greenfield, S., et al. Annals of Internal Medicine, 1985; 102:520-528 *
Blue Cross Blue Shield of Massachusetts p<0.001 14
15. Effect of a Patient Involvement on Clinical Outcomes:
Diabetes Control
14
12
10.59 10.61
10.26
10 9.06*
8 Experimental Group
Control Group
6
4
2
0
Glycosylated HbA1 (%) Glycosylated HbA1 (%)
Pre-Intervention Post-Intervention
Source: Greenfield, S., et al. J Gen Intern Med, 1988; 3:448-457 *
Blue Cross Blue Shield of Massachusetts p<0.001 15
16. Patient Reported Outcome Measures
(PROMs)
• Measures of a patient's health status or
health-related quality of life
• Standardized patient reported data,
collected over time in a consistent manner
so results can be measured, analyzed,
and used in research and care delivery.
• Provides information on key dimensions
of patient functional status and well-being;
inform diagnosis and treatment decisions.
• Quantifies the impact of treatments in
ways that can inform clinical practice and
quality measurement.
• Meaningful Use Phase II includes
requirement for PROMs
Blue Cross Blue Shield of Massachusetts 16
17. Near- and Longer-Term Promise of PROMs
Patients and Families
• Improved clinical interactions
• Empirical basis for treatment decisions
• Meaningful data on “quality” to inform choice
PROMs
Payers/Purchasers
• Tools to promote focus on health and Clinicians/Systems
health outcomes • Monitor patient progress
• Improved evidence base on efficacy • Data to guide treatment decisions
and basis for informed decision making • Improved evidence-base for care
• Ability to measure and improve • Compete on evidence of better results
outcomes
Blue Cross Blue Shield of Massachusetts 17
18. Summary & Implications
♦ A payment system that has delivered unsustainable cost growth,
unreliable quality, and inferior population health is giving way
♦ New models require accountability for quality, outcomes &
resource use
♦ Success is impossible without patient engagement
Clinical relationship quality is on the critical path
What role can technology play – imagine!
♦ Patient reported outcome measures (PROMs) have the potential to
revolutionize clinical encounters and value in health care
The promise of PROMs cannot be realized without technology-based
solutions
Blue Cross Blue Shield of Massachusetts 18
19. Questions and Comments
dana.safran@bcbsma.com
Blue Cross Blue Shield of Massachusetts 19
20. Introducing Our Panelists
• Joshua Feast, CEO & Founder, Cogito Health
• Kamal Jethwani, MD, MPH, Lead Research
Scientist, Partners Healthcare, Center for
Connected Health
• David C. Judge, MD, Medical Director,
Ambulatory Practice of the Future, Partners
Healthcare
Blue Cross Blue Shield of Massachusetts 20
Editor's Notes
Patient-Centered Care: What Difference Does it Make? Measuring and Improving Patient Care Experiences: From Research to Practice to National Quality Priority
There soon followed a slew of reports on the quality and safety of health care. <click> In 1998, the Institute of Medicine ’s National Roundtable issued a report called “the Urgent Need to Improve Quality.” <click> That same year, a Presidential Advisory Commission on Consumer Protection and Quality in the Health Care Industry was formed (?). <click> In 2000, the IOM published its landmark study “To Err is Human.” <click> A year later, the IOM published “Crossing the Quality Chasm” suggesting how to fix American Health Care. <click> Then in 2003, the RAND Corporation weighed in with an article in the New England Journal of Medicine called “The Quality of Health Care Delivered to Adults in the United States” which found that just over half of Americans get the recommended care. <<next slide>>
Before I describe the details of the Alternative Quality Contract model, I ’d like to give you some context. We have all heard that the health care industry is facing a crisis of increasing costs along with significant issues related to quality and safety of care. Many of these issues are unintended consequences of the dominant reimbursement model, fee-for-service, which rewards doctors and hospitals for the quantity and complexity of services provided instead of rewarding the quality and outcomes of care. To do our part as a health plan to move toward solutions, Blue Cross evaluated how our payment methodology could be changed to better support high-value health care.
Since 2009, Blue Cross Blue Shield of Massachusetts has engaged physicians and hospitals in a voluntary global payment model called the Alternative Quality Contract (AQC). The AQC is designed to decrease participating provider groups ’ spending trend at least in half by the end of five years, while producing significant, measurable improvements in quality. The AQC links financial incentives to clinical quality, patient outcomes, and overall resource use. Hospitals and physicians that choose to adopt the AQC agree to take responsibility for the full continuum of care received by their patients—including the cost and quality of that care—regardless of where the care is provided. The contract model combines a global budget for a patient population with significant performance incentives based on nationally endorsed quality measures (Figure 1).